ClinicalTrials.Veeva

Menu

Workplace-based HIV Self-testing Among Men in Uganda (WISe-Men)

M

Makerere University

Status

Unknown

Conditions

HIV Infections

Treatments

Device: Oral HIV Self-Test (OraQuick)

Study type

Interventional

Funder types

Other

Identifiers

NCT04164433
HS 2672 (Other Identifier)
SHSREC 2018-054

Details and patient eligibility

About

This study seeks to determine whether workplace delivery of HIV self-testing will lead to an increase in uptake of HIV testing and subsequent linkage to care or prevention services among men in Uganda.

Full description

The current coverage of HIV testing and counseling in Uganda is 60% with only 34% of these being men and only about 55% of males living with HIV know their status (MoH, 2016). The challenges with HIV testing require a new focus and new approaches to reach people with undiagnosed HIV infection.

HIV self-testing (HIVST) is one such innovative approach to making testing more accessible to several under-served populations such as men and key populations (WHO, 2013).

In this regard, this study seeks to determine whether providing HIVST in workplace settings will increase the uptake of HIV testing services among men employed in private security services in Uganda and improve linkage to treatment and prevention services.

Design: Cluster randomized trial in two Ugandan districts

Participants: Male employees of private security companies

Enrollment

548 estimated patients

Sex

Male

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Eligibility Criteria:

  • 18-60 years old
  • Employed >6 months in the private security company
  • Men who have not tested for HIV before
  • Men who tested HIV >one year ago

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

548 participants in 2 patient groups

Workplace-based HIV Self-Testing
Experimental group
Description:
i. Explain the procedure of conducting HIVST \& interpret HIV self- test result to the user. ii. Demonstrate how to perform the self-test and how to interpret the self-test result. iii. Provide appointment card including information on linkage for HIV prevention services and further testing for diagnosis among those with a reactive self-test. Participants with a non-reactive self-test will be referred to HIV prevention services. iv. Provide a toll free number for continued consultation
Treatment:
Device: Oral HIV Self-Test (OraQuick)
Workplace-based standard HIV Testing Services (HTS)
No Intervention group
Description:
Standard of care following the HIV testing algorithm .

Trial contacts and locations

2

Loading...

Central trial contact

Patience Muwanguzi, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems